What Pharma Executives Secretly Think About the Future (But Won’t Admit Publicly)
The Medical Futurist
MAY 12, 2025
The technology could even tailer medication doses to individual patients; but only one company, FabRx , has been spearheading this field. One early example is Roche’s acquisition of diabetes management app MySugr. Some 3D printed drugs made strides some years ago by getting FDA approvals and undergoing clinical trials.
52 
Let's personalize your content